EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EyeGate Pharmaceuticals Inc (EYEG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6419
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontophoresis to deliver optimal therapeutic levels of drug directly into the targeted ocular tissue; and CMHA-S platform is based on hyaluronic acid used in physiological processes such as development, wound healing, tissue homeostasis and joint lubrication. EGP-437, the company’s product in clinical trials, incorporates a reformulated corticosteroid, dexamethasone phosphate which is delivered into the ocular tissues. It also offers drug delivery mechanisms for treating diseases of the eye. EyeGate is headquartered in Waltham, Massachusetts, the US.

EyeGate Pharmaceuticals Inc (EYEG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EyeGate Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EyeGate Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Venture Financing 10
EyeGate Pharma Raises USD2.6 Million in Venture Financing 10
EyeGate Pharma Raises US$1 Million In Venture Financing 11
Partnerships 12
EyeGate Pharma Enters into Licensing Agreement with SentrX Animal Care 12
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 13
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents 15
Equity Offering 16
EyeGate Pharma Raises USD11.25 Million in Public Offering of Shares and Warrants 16
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants 18
EyeGate Pharmaceuticals Inc – Key Competitors 19
EyeGate Pharmaceuticals Inc – Key Employees 20
EyeGate Pharmaceuticals Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Mar 02, 2018: EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update 22
Aug 07, 2017: EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 24
May 08, 2017: EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update 26
Feb 23, 2017: EyeGate Pharmaceuticals Reports Full-year 2016 Financial Results and Provides Business Update 28
Corporate Communications 29
Jan 04, 2018: EyeGate Promotes Sarah Romano to Chief Financial Officer 29
Oct 23, 2017: Eye Care Thought Leaders Join EyeGate Scientific Advisory Board 30
Mar 13, 2017: EyeGate Pharmaceuticals appoints two new scientific advisory board members 31
Feb 06, 2017: EyeGate Pharmaceuticals Announces Executive Promotions 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
EyeGate Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EyeGate Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EyeGate Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EyeGate Pharma Raises USD2.6 Million in Venture Financing 10
EyeGate Pharma Raises US$1 Million In Venture Financing 11
EyeGate Pharma Enters into Licensing Agreement with SentrX Animal Care 12
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 13
Avedro Enters Into Licensing Agreement With EyeGate Pharma For Iontophoresis Patents 15
EyeGate Pharma Raises USD11.25 Million in Public Offering of Shares and Warrants 16
EyeGate Pharma Raises USD10 Million in Public Offering of Shares and Warrants 18
EyeGate Pharmaceuticals Inc, Key Competitors 19
EyeGate Pharmaceuticals Inc, Key Employees 20
EyeGate Pharmaceuticals Inc, Subsidiaries 21

List of Figures
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EyeGate Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • RattanIndia Power Ltd (RTNPOWER):企業の財務・戦略的SWOT分析
    RattanIndia Power Ltd (RTNPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Brembo SpA:戦略・SWOT・企業財務分析
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Celulosa Arauco y Constitucion SA:企業の戦略的SWOT分析
    Celulosa Arauco y Constitucion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • ABPA Holdings Ltd:企業の戦略的SWOT分析
    ABPA Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ormat Technologies Inc (ORA):企業の財務・戦略的SWOT分析
    Ormat Technologies Inc (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Koss Corp (KOSS):企業の財務・戦略的SWOT分析
    Summary Koss Corp (Koss) operates as an electronic equipment company that designs, manufactures and markets stereo headphones and other related accessory products. The company provides products such as full size headphones, earbuds and in-ear headphones, ear clip headphones, on-ear headphones, in-li …
  • Flex Pharma Inc (FLKS):製薬・医療:M&Aディール及び事業提携情報
    Summary Flex Pharma Inc (Flex Pharma) is a clinical-stage biotechnology company that offers discovery and development of innovative and proprietary treatments for muscle cramps, spasms and spasticity connected to the severe neurological diseases of ALS, MS, fibromyalgia, hypomagnesemia, hypocalcemia …
  • Ortho-Clinical Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ortho-Clinical Diagnostics Inc (OCD), a subsidiary of The Carlyle Group L.P., is a provider of in vitro diagnostic products and services. The company designs, develops, manufactures and distributes in-vitro diagnostic products. It serves clinical laboratories by providing comprehensive solut …
  • NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • Natus Medical Incorporated (BABY)-医療機器分野:企業M&A・提携分析
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. Its offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus also offers products for diagnostic hearing assessment in …
  • Pohjolan Voima Oy-エネルギー分野:企業M&A・提携分析
    Summary Pohjolan Voima Oy (Pohjolan) is a producer and supplier of electricity and heat. It conducts the designing, building, owning, operating, maintaining and decommissioning of power plants. The company generates electricity from various sources of energy such as hydro, nuclear and thermal. It al …
  • DalCor Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DalCor Pharmaceuticals Inc (DalCor Pharmaceuticals) researches and develops precision medicine for patients suffering from cardiovascular diseases. The company is engaged in development of Dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor which is intended to reduce cardiova …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Sigma-Tau HealthScience USA, Inc:企業の戦略・SWOT・財務情報
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData Plc (GD), formerly Progressive Digital Media Group Plc, is a provider of data insights, analytics and information services. The company’s solutions encompass market and competitive analysis, strategic planning, mergers and acquisitions, financial decisions, legal and accounting, m …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hunan Corun New Energy Co Ltd (600478):電力:M&Aディール及び事業提携情報
    Summary Hunan Corun New Energy Co Ltd (Corun) is a battery manufacturing company that designs, research's, produces and commercializes materials and batteries. The company develops high quality energy materials, extension products and advanced batteries, among others. It also manufactures ultra-inte …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):企業の財務・戦略的SWOT分析
    Torrent Pharmaceuticals Ltd (TORNTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆